China Yct International Group,'s Revenue in the fiscal year 2018 $ 64.94 millions
China Yct International Group,'s Revenue in the fiscal year 2017 $ 56.46 millions
China Yct International Group,'s Revenue in the fiscal year 2016 $ 47.83 millions
China Yct International Group,'s Revenue in the fiscal year 2015 $ 37.94 millions
China Yct International Group,'s Revenue in the fiscal year 2014 $ 34.06 millions
CYIG Revenue third quarter 2019 Y/Y Growth Comment
China Yct International Group, Inc. reported Revenue increase of 13.27% year on year in the third quarter 2019, to $ 19.49 millions, this is lower than China Yct International Group, Inc.'s recent average Revenue increase of 17.7%.
Looking into third quarter 2019 results within Major Pharmaceutical Preparations industry 129 other companies have achieved higher Revenue growth. While China Yct International Group, Inc.' s Revenue growth of 13.27% ranks overall at the positon no. 1768 in the third quarter 2019.
CYIG Revenue ( Y/Y Growth %)
2019
2018
2017
2016
4th Quarter
March
-
-20.26 %
102.51 %
-10.54 %
3rd Quarter
December
13.27 %
21.45 %
19.48 %
24.71 %
2nd Quarter
September
34.68 %
19.67 %
-17.92 %
62.86 %
1st Quarter
June
21.95 %
76.42 %
-15.49 %
40.46 %
FY
-
15.04 %
18.02 %
-
Financial Statements
China Yct International Group,'s third quarter 2019 Revenue
Revenue by Quarter for the Fiscal Years 2016, 2017, 2018, 2019
China Yct International Group,'s Q/Q Revenue Growth
Revenue Q/Q Growth Statistics
High
Average
Low
71.86 %
5.39 %
-34.69 %
(Dec 31 2010)
CYIG's III. Quarter Q/Q Revenue Comment
China Yct International Group, Inc. achieved in the III. Quarter 2019 below company average Revenue growth of 4.36% quarter on quarter, to $ 19.49 millions.
Within Major Pharmaceutical Preparations industry 172 other companies have achieved higher Revenue quarter on quarter growth. While China Yct International Group,'s Revenue growth quarter on quarter, overall rank is 2391.
China Yct International Group, Inc. achieved in the III. Quarter 2019 below company average Revenue growth of 4.36% quarter on quarter, to $ 19.49 millions.
Within Major Pharmaceutical Preparations industry 172 other companies have achieved higher Revenue quarter on quarter growth. While China Yct International Group,'s Revenue growth quarter on quarter, overall rank is 2391.
China Yct International Group,'s 12 Months Revenue Growth Year on Year
Revenue TTM Growth
12 Months Ending (Dec 31 2018)
12 Months Ending (Sep 30 2018)
12 Months Ending (Jun 30 2018)
12 Months Ending (Mar 31 2018)
12 Months Ending (Dec 31 2017)
Cumulative Revenue 12 Months Ending
$ 75.80
$ 73.51
$ 68.70
$ 64.94
$ 69.20
Y / Y Revenue Growth (TTM)
9.54 %
11.12 %
7.53 %
15.02 %
50.96 %
Year on Year Revenue Growth Overall
Ranking
# 432
# 1543
# 1612
# 1222
# 2067
Seqeuential Revenue Change (TTM)
3.11 %
7.01 %
5.78 %
-6.15 %
4.59 %
Seq. Revenue Growth (TTM) Overall
Ranking
# 2345
# 897
# 818
# 3600
# 908
Cumulative Revenue growth Comment
Assuming the China Yct International Group,'s fiscal year would have ended in Dec 31 2018, China Yct International Group, would have reprted above average annual Revenue improvement of 9.54% year on year, of $ 76 millions. This marks a slow-down of the companys growth trends and from the 11.12% rise in Sep 30 2018.
In the Healthcare sector 113 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 432, from total ranking in previous quarter at 1543.
Assuming the China Yct International Group,'s fiscal year would have ended in Dec 31 2018, China Yct International Group, would have reprted above average annual Revenue improvement of 9.54% year on year, of $ 76 millions. This marks a slow-down of the companys growth trends and from the 11.12% rise in Sep 30 2018.
In the Healthcare sector 113 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 432, from total ranking in previous quarter at 1543.
About China Yct International Group, Revenue Growth Rates (CYIG), Current and Historic Growth - CSIMarket Analysis
How we calculate this
This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years).
Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
22.77%